Meeting Highlights Information Registration Visa Letter Application Programme Overview Exhibition Virtual Exhibition Hotels Exhibition Virtual Exhibition Satellite Programme


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Ocular toxoplasmosis (panuveitis): a case report

Poster Details


First Author: T.Elongo MOROCCO

Co Author(s): L. Kora   L. El Maaloum   B. Allali   A. El Kettani           

Abstract Details

Purpose:

Uveitis is one of the major causes of blindness in the world and toxoplasmosis is the most common cause of eye inflammation in the world. It is caused by the infection with toxoplasma gondi through congenital or acquired routes. Rapid clinical evolution incite to use good diagnosis tools in order to promptly start therapy.

Setting:

Pediatric ophthalmologic department of hospital 20 aout 1953 of Casablanca in Morocco, university Hassan 2

Methods:

A 30-year-old female patient consults in ophtalmic emergencies. She is diabetic treated with insulin; she is not infected by HIV and doesn’t have any cancer. She consults for painful red right eye with decreased visual acuity since 4 days. She never had similar symptoms before.

Results:

On ophthalmic examination of right eye, visual acuity was 20/200, there were cells in the anterior chamber, vitreous cells and typical active retinochoroiditis lesion. There was no scare spot. Fundus fluorescein angiography revealed early hypofluorescence and late intense hyperfluorescence with fuzzy margins of the retinochoroiditis lesion. We detected high level of IgG antibodies in serum but not IgM. Trimethoprim/sulfamethoxazole, corticosteroids and mydriatics were given to the patient. The patient recovered an excellent visual acuity 20/20 after treatment.

Conclusions:

When we find unilateral retinochoroiditis lesion we should evoke acquired ocular toxoplasmosis with determination of serum antibody levels IgG and IgM. The use of serology and PCR of aqueous humor should allow rapid diagnosis in atypical cases.

Financial Disclosure:

None

Back to Poster listing